← Back to Search

Anticoagulation and Thrombosis Point of Care Test(AT-POCT) for Anticoagulation and Thrombosis Test

N/A

Waitlist Available

Led By Ashutosh Chilkoti, PhD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 study day

Awards & highlights

Study Summary

This trial is testing a new, low-cost test to help monitor markers for anticoagulation and thrombosis for patients with advanced heart failure.

Eligible Conditions

Anticoagulation and Thrombosis Point of Care Test

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 study day

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 study day

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 study day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Interclass correlation between PT/INR and LDH measurements

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Anticoagulation and Thrombosis Point of Care Test (AT-POCT)Experimental Treatment2 Interventions

Group II: Duke Central Automated Laboratory (DCAL)Active Control2 Interventions

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,375 Previous Clinical Trials

3,426,923 Total Patients Enrolled

Ashutosh Chilkoti, PhDPrincipal InvestigatorDuke University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there capacity for additional participants in this research endeavor?

"As indicated by clinicaltrials.gov, this medical trial is no longer searching for patients; it was initially posted on July 1st 2023 and last modified on October 6th 2022. Nevertheless, there are 162 other trials actively seeking candidates at the moment."

Answered by AI

Are individuals beyond the age of 35 being enrolled as participants in this investigation?

"The required participant qualifications for this research are ages 18 to 80. The trial also features 12 separate studies specifically targeting those younger than 18 and 153 trials that target the elderly aged 65 or above."

Answered by AI

Am I eligible to enroll in this clinical research study?

"The trial is recruiting sixty participants aged 18 to 80, who have thrombus. Additionally, the LVAD patient cohort must be on LVAD support for between two weeks and ten years."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Point of Care Testing to Improve Monitoring of LVAD Patients

2023. "Point of Care Testing to Improve Monitoring of LVAD Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03555552.